ArticleCancer medicine2026

Second Line Treatment Decision as Per Standard of Care or Foundation Medicine in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer.

Federico Rojo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.